Handmade quality · Free shipping over $75 · Explore the atelier

BAY-899 26545 which has entered clinical trial

SKU: 23230539800

4.8
USD100.00 USD129.00

Pay in 4 interest-free payments of $25.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

which has entered clinical trial for asthma and eosinophilic bronchitis

Solubility: DMSO : 50 mg/mL (179

Solubility: H2O : 93

and blocking mutant RAS-driven signaling and cell proliferation

human is a melanocortin 4 (MC4R) receptor agonist

BAY-899 26545 which has entered clinical trialBAY 899 is an orally active and selective luteinizing hormone receptor (LH R) antagonist with IC50s of 185 nM and 46nM for hLH (human LH) and rLH (rat LH), respectively. BAY 899 can reduce sex hormone levels. Product information CAS Number: 2471967 92 5 Molecular Weight: 459. 45 Formula: C25H19F2N5O2 Chemical Name: (5S) N [2 (4 fluorophenoxy)pyrimidin 5 yl] 5 (4 fluorophenyl) 5,6,7,8 tetrahydro 1,6 naphthyridine 6 carboxamide Smiles:

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products